Cross-referencing clinical data
A pairing appears on this page only when a trial gave both ingredients together and measured the result. Grass-leaved calamus has none that clears that bar.
Stitching two separate single-ingredient studies into a pairing is the one thing this engine will not do. When a study of the combination itself holds up at source, it lands here with its citation.
No invented synergy. Where actives were studied on their own rather than together, the record shows each on its own evidence, never a combined effect no trial measured.
Research strength. Research strength says how much work stands behind the combination. It is never a product score.
Independent record. Every finding is cited to a named trial, dated, and never written by the brand.
20 pairings are live across the library today. Checked 20 July 2026.
No study gave these as a pair, so they are not in the card above. But the reason they belong together is settled biochemistry, not a guess, so it is worth knowing.
The characteristic fraction of Acorus gramineus rhizome is a volatile oil carrying beta-asarone and related phenylpropanoids, and those molecules are lipophilic and poorly held in water. A medium-chain triglyceride carrier keeps them in solution in a softgel or a liquid and slows loss of the volatile fraction during storage. This is formulation chemistry rather than a clinical finding, so it says nothing about what the oil does once absorbed.
Grass-leaved calamus rhizome and Polygala root appear together in long-standing East Asian formulas built around mental clarity and calm. The pairing is documented by formulary tradition, not by controlled work that separated one plant from the other. Read it as a convention with historical weight and no human efficacy data behind the specific combination.
Panax ginseng sits alongside Acorus rhizome in several traditional multi-herb preparations aimed at alertness. No controlled trial has tested the two together in isolation, so the grounding is textual and historical. The combination is formulation convention.
Modern cognition blends often place calamus rhizome next to Bacopa because both carry a long traditional record in the same use category. Bacopa has human trial data of its own, calamus does not, so the blend borrows credibility it has not earned on the calamus side. Anyone reading a label should assume the measured effects belong to the ingredient that was actually studied.
Acorus gramineus volatile oil produces sedative-type behaviour in rodent models, and valerian is taken specifically for its calming effect. Stacking two sedating preparations can produce more drowsiness than either alone, which matters for driving and for anyone already on a sedating medicine. The animal grounding means this is a caution to respect, not a measured human interaction.
Nothing specific on file for Grass-leaved calamus. Match the label to the daily amount above, and tell your doctor what you take.
Not medical advice. Show the label to your pharmacist.FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This information is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.